Amicus Therapeutics (FOLD) Misses Q1 EPS by 14c

Amicus Therapeutics (NASDAQ: FOLD) reported Q1 EPS of ($0.35), $0.14 worse than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Isabella Bank added to Russell 2000 index after Nasdaq listing
• Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy